The Recombinant Chemicals Market Size is valued at USD 2.87 billion in 2023 and is predicted to reach USD 4.67 billion by the year 2031 at a 6.4% CAGR during the forecast period for 2024-2031.
Recombinant chemicals are products or substances that are generated using recombinant DNA technology, which involves combining DNA from multiple sources to create novel genetic combinations. Biotechnology frequently use this procedure to produce a wide range of chemicals, proteins, enzymes, and other biological substances utilized in the fields of medicine, agriculture, and industry. Recombinant DNA technology has revolutionized the treatment and management of genetic illnesses through the creation of therapeutic products. Recombinant proteins are used to create and improve vaccines. Their rising demand is being driven by their application in several medical fields, including drug discovery, therapies, and diagnostics.
Additionally, there are a lot of opportunities in the recombinant chemicals market, and recombinant chemicals are growing in popularity as a result of the improved genetic engineering that is generating new ideas in agriculture, health, and industry. The increasing demand for biologics and tailored treatment bodes well for the industry.
However, the market expansion of the recombinant chemicals sector is impeded by factors such as the ethical considerations of genetic engineering, the complexity of regulations, and the high production costs. Furthermore, the recombinant chemicals market was positively affected by the COVID-19 pandemic because the demand for vaccinations and medicines was accelerated, demonstrating the significance of recombinant technology. As a result, healthcare and biotechnology saw a surge in investment in R&D, which fueled innovation and opened up new avenues for application.
Moreover, innovative goods in the recombinant chemicals market are developed through collaboration between enterprises in the biotechnology industry, research institutes, pharmaceutical corporations, and other rising research and development capacities, manufacturing procedures, and recombinant chemical technology breakthroughs in the pharmaceutical, diagnostic, and industrial sectors.
The recombinant chemicals market is segmented based on product type, technology, and application. Based on product type category, the market is divided into recombinant proteins, recombinant DNAs, recombinant peptides, and others. By technology, the market is segmented into microbial expression systems, mammalian cell expression systems, yeast expression systems, insect cell expression systems, and cell-free expression systems. By application category, the market is segmented into drug development, vaccine production, therapeutics, cell line development, agriculture, food and beverage, and others.
The recombinant proteins in the recombinant chemicals market are expected to hold a major global market share in 2023 because they play an essential part in creating biological medicines, vaccines, and diagnostic instruments. Their uptake is being propelled by the rising number of chronic diseases and the need for tailored therapy. The availability and affordability of recombinant proteins for use in biotechnology and pharmaceuticals have been greatly improved by recent developments in bioprocessing and genetic engineering, which have increased production yield and efficiency.
The microbial expression systems segment is expanding rapidly in the recombinant chemicals market because they generate large quantities of recombinant proteins at little cost and with little effort. Their rapid growth rates and ease of genetic manipulation make them perfect for industrial-scale manufacturing. The rising demand for recombinant proteins in pharmaceuticals and industrial applications is being met by progressively enhancing microbial expression systems' capabilities through developments in fermentation technology and genetic engineering, which is increasing their market usage even further.
The North American recombinant chemicals market is expected to note the highest revenue share in the near future. This can be attributed to the excellent biotechnology sector, great research and development capacity, favourable regulatory environment, and presence of top pharmaceutical corporations promoting the acceptance of recombinant chemical technologies. In addition, Asia Pacific is likely to develop rapidly in the global recombinant chemicals market because of rising biotechnology investments, a developing pharmaceutical sector, government policies supporting this sector, and rising demand for creative healthcare solutions throughout the region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 2.87 Bn |
|
Revenue Forecast In 2031 |
USD 4.67 Bn |
|
Growth Rate CAGR |
CAGR of 6.4% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, Technology, And Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Genentech, Inc., Amgen Inc., Biogen, Pfizer, Inc., Novartis AG, Merck & Co., Sanofi, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., and Bayer AG.and Others. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Recombinant Chemicals Market Snapshot
Chapter 4. Global Recombinant Chemicals Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product Type:
5.2.1. Recombinant Proteins
5.2.2. Recombinant DNAs
5.2.3. Recombinant Peptides
5.2.4. Others
Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis
6.1. By Technology & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Technology:
6.2.1. Microbial Expression Systems
6.2.2. Mammalian Cell Expression Systems
6.2.3. Yeast Expression Systems
6.2.4. Insect Cell Expression Systems
6.2.5. Cell-free Expression Systems
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
7.2.1. Drug Development
7.2.2. Vaccine Production
7.2.3. Therapeutics
7.2.4. Cell Line Development
7.2.5. Agriculture
7.2.6. Food and Beverage
7.2.7. Others
Chapter 8. Recombinant Chemicals Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.1.2. North America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
8.1.3. North America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.4. North America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031.
8.2. Europe
8.2.1. Europe Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.2.2. Europe Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
8.2.3. Europe Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.4. Europe Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.3.2. Asia Pacific Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
8.3.3. Asia Pacific Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.4. Asia Pacific Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Asia Pacific Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.4.2. Latin America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
8.4.3. Latin America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.4. Latin America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031.
8.5. Middle East & Africa
8.5.1. Middle East & Africa Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.5.2. Middle East & Africa Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
8.5.3. Middle East & Africa Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.4. Middle East & Africa Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Genentech, Inc.
9.2.2. Amgen Inc.
9.2.3. Biogen
9.2.4. Pfizer, Inc.
9.2.5. Novartis AG
9.2.6. Merck & Co.
9.2.7. Sanofi
9.2.8. F. Hoffmann-La Roche AG
9.2.9. Johnson & Johnson Services, Inc.
9.2.10. Bayer AG
9.2.11. Other Prominent Players
Recombinant Chemicals Market By Product Type-
Recombinant Chemicals Market By Technology-
Recombinant Chemicals Market By Application-
Recombinant Chemicals Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
